Abstract
BackgroundBoceprevir (BOC) and telaprevir (TLV) have been approved recently for the treatment of chronic hepatitis C virus (HCV) infection but their safety remains to be studied.PurposeTo analyse the incidence of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have